In this study, serum IgE and IL-4 levels were evaluated at baseline and after 6 months of chemotherapy as a hallmark of post-chemotherapy allergic susceptibility mediators to show whether changes in their level is associated with hypersensitivity presentations in pediatric ALL patients during high-dose intensive chemotherapy. The gene discussed is IL4; the disease is acute lymphoblastic leukemia.